Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 8-K Event Regulation FD disclosure · Other events
  8. 8-K Event Regulation FD disclosure
  9. UPLOAD Other SEC-generated Letter
  10. S-3 Offering Registration Statement
  11. S-3 Offering Registration Statement
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 6 of 34 · 662 filings